Showing results (1031-1040 of 1,163) with videos related to
Sort By:
Pageof 117
European Journal of Heart Failure|November 7, 2022
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartanMingming Yang, Jawad H Butt, Toru Kondo, et al.NEJM Evidence|February 6, 2024
Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER TrialsToru Kondo, Samvel B Gasparyan, Pardeep S Jhund, et al.Journal of the American College of Cardiology|April 30, 2025
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled AnalysisMaria A Pabon, Gerasimos Filippatos, Brian L Claggett, et al.European Journal of Heart Failure|April 29, 2025
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HFToru Kondo, Pardeep S Jhund, Alasdair D Henderson, et al.JAMA Cardiology|March 29, 2025
Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialShingo Matsumoto, Alasdair D Henderson, Pardeep S Jhund, et al.JAMA Cardiology|May 21, 2025
Finerenone in Heart Failure With Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialMaria A Pabon, Orly Vardeny, Muthiah Vaduganathan, et al.European Journal of Heart Failure|March 6, 2020
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, et al.ESC Heart Failure|September 21, 2020
Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trialJingyuan Mao, Jian Zhang, Carolyn S P Lam, et al.Journal of the American College of Cardiology|August 30, 2022
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.JAMA Cardiology|May 20, 2023
Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER TrialAlexander Peikert, Alvin Chandra, Mikhail N Kosiborod, et al.Pageof 117